ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 282

Angiogenesis in Fasciitis Associated with Dermatomyositis

Ken Yoshida, Kentaro Noda, Taro Ukichi, Kazuhiro Furuya, Kenichiro Hirai, Isamu Kingetsu and Daitaro Kurosaka, Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Angiogenesis, cytokines, dermatomyositis, inflammation and polymyositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: We have previously demonstrated that fasciitis is a common lesion of dermatomyositis (DM) detectable early after disease onset. Furthermore, en bloc biopsy showed that the fascial microvasculature, rather than intramascular microvasculature, is one of the primary sites for inflammatory cell infiltration (Arthritis Rheum. 2010;62:3751-9). We also showed that fasciitis was detectable by Power Doppler ultrasonography in patients with DM. In the current study, we examined whether angiogenesis was observed in fasciitis associated with DM, and which angiogenesis-related factors were expressed.

Methods: We analyzed 12 patients consisting of 6 newly diagnosed with DM and 6 newly diagnosed with polymiositis (PM) in the Division of Rheumatology at Jikei University Hospital. In the current study, all patients underwent en bloc biopsy before treatment. All samples were fixed in 10% neutral-buffered formalin and embedded in paraffin. Total vascular inflammation score (TVIS) was defined as the total number of aggregates of ≥50 perivascular inflammatory cells per 4-mm2area of the fascia in the 3 fields with the most remarkable perivascular infiltrates in order to evaluate the severity of fasciitis. Immunohistochemical staining was performed on paraffin-embedded sections by using anti-CD31 antibodies to evaluate angiogenesis, and anti-VEGF, anti-IL-6, and anti-TNF-α antibodies to evaluate the expression of angiogenesis-related factors in the fascia. Angiogenesis score (AS) was defined as the total number of CD31-positive blood vessels in the 3 high-power fields (200×) that showed the most remarkable proliferation of the vessels in the fascia. The numbers of VEGF, IL-6, and TNF-α positive cells were counted in the 3 high-power fields (400×) that showed the largest accumulation of these positive cells.

Results: Significant fasciitis, histologically defined as TVIS of ≥3, was detected in all patients with DM. Although mild inflammation of the fascia (TVIS 1) was observed in 1/6 patients with PM, significant fasciitis was not detected in any patients with PM. TVIS and AS in the fascia were significantly higher in patients with DM compared with PM. AS was positively correlated with TVIS in DM-associated fasciitis. The numbers of VEGF and TNF-α positive cells were both significantly higher in the fascia of patients with DM compared with PM. IL-6 positive cells were barely present in the fascia among patients with DM and PM.

Conclusion: Angiogenesis was predominantly observed in the fascia with severe inflammation among patients with DM. Our data suggest that VEGF and TNF-α are involved in DM-associated fasciitis with angiogenesis. Inhibiting VEGF and TNF-α may be a useful therapeutic option to treat inflammatory myopathy, especially DM.


Disclosure: K. Yoshida, None; K. Noda, None; T. Ukichi, None; K. Furuya, None; K. Hirai, None; I. Kingetsu, None; D. Kurosaka, None.

To cite this abstract in AMA style:

Yoshida K, Noda K, Ukichi T, Furuya K, Hirai K, Kingetsu I, Kurosaka D. Angiogenesis in Fasciitis Associated with Dermatomyositis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/angiogenesis-in-fasciitis-associated-with-dermatomyositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/angiogenesis-in-fasciitis-associated-with-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology